245743-64-0

Basic information

• Product Name: methyl 5-chloro-2-fluoro-4-hydroxybenzoate
• Synonyms: methyl 5-chloro-2-fluoro-4-hydroxybenzoate
• CAS NO: 245743-64-0
• Molecular Formula: C₈H₆ClFO₃
• Molecular Weight: 204.5828432
• EINECS: -0
• Mol File: 245743-64-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: methyl 5-chloro-2-fluoro-4-hydroxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-chloro-2-fluoro-4-hydroxybenzoate(245743-64-0)
• EPA Substance Registry System: methyl 5-chloro-2-fluoro-4-hydroxybenzoate(245743-64-0)

Safety Data

• Hazardous Substances Data: 245743-64-0(Hazardous Substances Data)

Usage

General Description

Methyl 5-chloro-2-fluoro-4-hydroxybenzoate is a chemical compound with the molecular formula C8H6ClFO3. It is a derivative of benzoic acid and belongs to the class of organic compounds known as salicylic acid and derivatives. methyl 5-chloro-2-fluoro-4-hydroxybenzoate is commonly used in the production of pharmaceuticals and industrial chemicals. It has antimicrobial and anti-inflammatory properties, making it useful in various medicinal applications. Additionally, it has been reported to have potential for use as a pesticide and a fungicide due to its ability to inhibit the growth of microorganisms.

Upstream product

• 197507-22-5 methyl 2-fluoro-4-hydroxybenzoate 
• 67-56-1 methanol 
• 593280-19-4 5-chloro-2-fluoro-4-hydroxy-benzoic acid 
• 65145-13-3 2-fluoro-4-hydroxybenzoic acid 
• 211172-72-4 5-chloro-2-fluoro-4-methoxybenzoic acid 
• 245743-63-9 methyl 5-chloro-4-methoxy-2-nitrobenzoate 
• 74127-07-4 5-chloro-4-methoxy-2-nitrobenzoic acid 
• 79025-26-6 methyl 2-amino-5-chloro-4-methoxybenzoate 
• 130017-52-6 5-acetylamino-4-methoxy-2-nitrobenzoic acid 
• 204254-70-6 5-amino-4-methoxy-2-nitro-benzoic acid 
• 211172-73-5 methyl 5-chloro-2-fluoro-4-methoxybenzoate 

Downstream Products

• 211172-74-6 (R)-5-chloro-2-fluoro-4-(2-octyloxy)benzoate 

Relevant articles and documents

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS

The present invention discloses compounds according to Formula (I) Wherein R1, R2, L, A1, A2, A3, Cy and the subscript n are as defined herein. The present invention relates to antagonists compounds of sphingosine 1-phosphate (SIP) receptor, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, inflammatory diseases, respiratory diseases, autoimmune diseases, metabolic diseases, cardiovascular diseases, and/or proliferative diseases by administering the compound of the invention.

Design of photonic liquid crystal materials: Synthesis and evaluation of new chiral thioindigo dopants designed to photomodulate the spontaneous polarization of ferroelectric liquid crystals

Irradiation of a ferroelectric S(c)* liquid crystal phase induced by the photochromic dopants (R,R)-6,6'-bis(2-octyloxy)-5,5'-dinitrothioindigo and (R,R)-5,5'-dichloro-6,6'-bis(2-octyloxy)thioindigo at λ=514 and 532 nm, respectively, causes an increase in spontaneous polarization (P(s)) by a factor ranging from 1.4 to 4.0. This increase in P(s) is achieved without concomitant destabilization of the S(c)* phase, and is consistent with an increase in transverse dipole moment of the thioindigo core as a result of trans-cis photoisomerization. The contribution of the thioindigo core towards P(s) is achieved through stereo-polar coupling with the chiral side-chains, which is enhanced by the presence of the nitro and chloro substituents.